Trials / Unknown
UnknownNCT05092048
A Study for PRO of CML in Real Word
Validation Value of the Questionnaire to Assess Health-related Quality of Life in Patients With CML
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- xuna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Successful outcomes in CML require both prolonged adherence to oral TKI therapy by patients and careful monitoring of treatment responses by their physicians. Patient Reported Outcomes(PRO) assessment is important to facilitate decisions in the current treatment landscape of CML.
Detailed description
1. Above 18 years of age. 2. Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML). 3. Written informed consent. 4. Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | PHQ-9 and GAD-7 questionnaire |
Timeline
- Start date
- 2021-09-22
- Primary completion
- 2022-09-30
- Completion
- 2022-10-01
- First posted
- 2021-10-25
- Last updated
- 2021-10-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05092048. Inclusion in this directory is not an endorsement.